CHG

512

-0.39%↓

CHG

512

-0.39%↓

CHG

512

-0.39%↓

CHG

512

-0.39%↓

CHG

512

-0.39%↓

Search

Halma PLC

Cerrado

SectorAcciones industriales

3,616 0.11

Resumen

Variación precio

24h

Actual

Mínimo

3590

Máximo

3662

Métricas clave

By Trading Economics

Ingresos

107M

187M

Ventas

651M

1.2B

P/B

Media del Sector

39.217

47.787

BPA

0.553

Rentabilidad por dividendo

0.67

Margen de beneficios

15.096

Empleados

9,000

EBITDA

184M

317M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+4.08% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.67%

2.01%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-166M

14B

Apertura anterior

3615.89

Cierre anterior

3616

Noticias sobre sentimiento de mercado

By Acuity

31%

69%

103 / 408 Clasificación en Industrials

Halma PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

10 feb 2026, 23:26 UTC

Principales Movimientos del Mercado

Moderna Stock Slips After FDA Refuses Flu Vaccine Review

10 feb 2026, 22:31 UTC

Ganancias

Correction to America Movil 4Q Profit Article

10 feb 2026, 22:22 UTC

Ganancias

America Movil 4Q Profit Jumps on Lower Financial Costs

10 feb 2026, 23:51 UTC

Charlas de Mercado
Ganancias

Commonwealth Bank's Margin Management Gives It a Platform -- Market Talk

10 feb 2026, 23:42 UTC

Charlas de Mercado

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

10 feb 2026, 23:40 UTC

Charlas de Mercado
Ganancias

Commonwealth Bank Bear Says 1H Result Looks Strong -- Market Talk

10 feb 2026, 23:21 UTC

Charlas de Mercado

Ford Says EV Shift Was Driven by Demand Changes -- Market Talk

10 feb 2026, 23:21 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

10 feb 2026, 22:17 UTC

Charlas de Mercado

Australia's One Nation Now Commands Working Class Vote -- Market Talk

10 feb 2026, 22:15 UTC

Ganancias

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

10 feb 2026, 22:10 UTC

Ganancias

Intact Financial 4Q Book Value Per Share Was C$107.35 >IFC.T

10 feb 2026, 22:10 UTC

Ganancias

Intact Financial Raises Qtr Dividend to C$1.47 >IFC.T

10 feb 2026, 22:09 UTC

Ganancias

Intact Financial 4Q Combined Ratio Was 85.9% >IFC.T

10 feb 2026, 22:09 UTC

Ganancias

Intact Financial 4Q Adj EPS C$5.50 >IFC.T

10 feb 2026, 22:01 UTC

Ganancias

Intact Financial 4Q EPS C$5.24 >IFC.T

10 feb 2026, 21:54 UTC

Ganancias

James Hardie Industries Sees FY26 Total Adjusted EBITDA $1.232B to $1.263B >JHX

10 feb 2026, 21:53 UTC

Ganancias

Robinhood Stock Tumbles as Crypto-Related Revenue Falls Short of Expectations -- Barrons.com

10 feb 2026, 21:51 UTC

Ganancias

James Hardie Industries Sees FY26 Free Cash Flow at Least $200M

10 feb 2026, 21:51 UTC

Ganancias

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 feb 2026, 21:51 UTC

Ganancias

James Hardie Industries: Focused on the Achievement of $125 M Target >JHX

10 feb 2026, 21:51 UTC

Ganancias

James Hardie Industries: Integration and Cost Synergies Ahead of Schedule >JHX

10 feb 2026, 21:51 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Evolution Net Debt A$362 Million at Dec. 31 Vs A$1.29 Billion Year Earlier

10 feb 2026, 21:50 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Evolution: Gearing 6% at Dec. 31, From 23% a Year Earlier

10 feb 2026, 21:50 UTC

Ganancias

James Hardie Industries 3Q EPS 12c >JHX

10 feb 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

10 feb 2026, 21:50 UTC

Ganancias

James Hardie Industries 3Q Adj EPS 24c >JHX

10 feb 2026, 21:49 UTC

Ganancias

James Hardie Industries 3Q Sales $1.24B >JHX

10 feb 2026, 21:49 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Evolution 1H Operating Mine Cash Flow a Record A$1.73 Billion

10 feb 2026, 21:48 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Evolution 1H Ebitda A$1.56 Billion, Up 59% On-Year

10 feb 2026, 21:47 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Evolution 1H Revenue A$2.79 Billion, Up 37% On-Year

Comparación entre iguales

Cambio de precio

Halma PLC previsión

Precio Objetivo

By TipRanks

4.08% repunte

Estimación a 12 Meses

Media 3,755.07 GBX  4.08%

Máximo 4,200 GBX

Mínimo 2,490 GBX

De acuerdo con 13 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Halma PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

13 ratings

7

Comprar

5

Mantener

1

Vender

Sentimiento

By Acuity

103 / 408 Clasificación en Acciones industriales

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Halma PLC

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
help-icon Live chat